Analyzing gene expression data from 594 breast cancer samples using the HTG Oncology and Immuno-oncology panels, 119 TN and 475 HR + HER2− from The Cancer Genome Atlas (TCGA), we found two distinct subgroups of immune-high and immune-low tumors in both subtypes. This evidence concerns the gene ERBB2 and breast cancer.